Pampa Energia SA(PAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PAM Pampa Energia SA

Trading 05-13 11:17:46 EDT

80.86

-1.54

-1.87%

High82.30	Low80.43	Vol24.64K
Open82.30	D1 Closing82.40	Amplitude2.27%
Mkt Cap4.35B	Tradable Cap2.19B	Total Shares53.74M
T/O2.00M	T/O Rate0.09%	Tradable Shares27.10M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PAM","market":"US","secType":"STK","nameCN":"Pampa Energia SA","latestPrice":80.855,"timestamp":1778685442762,"preClose":82.4,"halted":0,"volume":24641,"delay":0,"changeRate":-0.01875000000000002,"floatShares":27103400,"shares":53744000,"eps":8.1313,"marketStatus":"Trading","change":-1.545,"latestTime":"05-13 11:17:46 EDT","open":82.3,"high":82.3,"low":80.43,"amount":2003552.81052,"amplitude":0.022694,"askPrice":81.41,"askSize":12,"bidPrice":80.81,"bidSize":100,"shortable":3,"etf":0,"ttmEps":8.1313,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778702400000},"marketStatusCode":2,"adr":1,"adrRate":25,"listingDate":1162789200000,"exchange":"NYSE","adjPreClose":82.4,"preHourTrading":{"tag":"盘前","latestPrice":81.84,"preClose":82.4,"latestTime":"09:18 EDT","volume":55,"amount":4531.2002999999995,"timestamp":1778678286120,"change":-0.56,"changeRate":-0.006796,"amplitude":0.007282},"postHourTrading":{"tag":"盘后","latestPrice":82.4,"preClose":82.4,"latestTime":"16:37 EDT","volume":438,"amount":36087.8,"timestamp":1778618263751,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.298294,"impliedVol":0.3243,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/PAM","defaultTab":"news","newsList":[{"id":"2635334427","title":"Argentine Stocks Decline 1.2% In Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2635334427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635334427?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:25","pubTimestamp":1778682300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Argentina fell during early trading Wednesday, as the S&P MERVAL Index declined 1.2% to 2759251.16.Among local companies with a market cap of at least 500 billion Argentine pesos , Import y Export Patagonia is the biggest early laggard, falling 3.6%, followed by shares of Capex, which dropped 2.6%. Shares of Holcim  declined 1.9%.Pampa Energia is the biggest leader this morning, rising 1.7%, and Aluar Alum Argentino I increased 1.6%. Naturgy BAN rounds out the top three movers, as shares climbed 0.5%.On the currency front, the WSJ Dollar Index added 0.1% to 95.19. The dollar weakened 0.1% against the peso to 1,386.48 pesos.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4081","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634828062","title":"Argentine Stocks Gain 0.7% In Early Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634828062","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634828062?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:25","pubTimestamp":1778509500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Argentina rose during early trading Monday, as the S&P MERVAL Index added 0.7% to 2787277.23.Among local companies with a market cap of at least 500 billion Argentine pesos , Molinos Rio de la Plata is the biggest leader this morning, adding 1.7%, and Pampa Energia increased 1.4%.Capex is the biggest early laggard, declining 1.7%, followed by shares of Import y Export Patagonia, which dropped 1.6%. Shares of Holcim  declined 1.5%.On the currency front, the WSJ Dollar Index rose 0.1% to 94.74. The dollar weakened 0.3% against the peso to 1,401.50 pesos.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAM","BK4081","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633125107","title":"Argentine Stocks Decline 1.4% In Early Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2633125107","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633125107?lang=en_us&edition=fundamental","pubTime":"2026-05-07 22:25","pubTimestamp":1778163900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Argentina fell during early trading Thursday, as the S&P MERVAL Index declined 1.4% to 2839902.86.Among local companies with a market cap of at least 500 billion Argentine pesos , Capex is the biggest early laggard, declining 2.5%, followed by shares of Aluar Alum Argentino I, which fell 1.7%. Shares of Molinos Rio de la Plata fell 1.6%.Pampa Energia is the biggest leader this morning, rising 2.9%, and Naturgy BAN added 2.2%.On the currency front, the WSJ Dollar Index fell 0.2% to 94.65. The dollar strengthened 0.1% against the peso to 1,386.72 pesos.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","PAM","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633462163","title":"Pampa Energia Q1 EPS $3.90 Beats $1.58 Estimate, Sales $573.000M Miss $629.919B Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633462163","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633462163?lang=en_us&edition=fundamental","pubTime":"2026-05-07 06:05","pubTimestamp":1778105137,"startTime":"0","endTime":"0","summary":"Pampa Energia (NYSE:PAM) reported quarterly earnings of $3.90 per share which beat the analyst consensus estimate of $1.58 by 146.84 percent. This is a 39.29 percent increase over earnings of $2.80 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52351383/pampa-energia-q1-eps-3-90-beats-1-58-estimate-sales-573-000m-miss-629-919b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pampa Energia Q1 EPS $3.90 Beats $1.58 Estimate, Sales $573.000M Miss $629.919B Estimate.","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAM","BK4563","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633968977","title":"Pampa Energia SA  expected to post earnings of $1.15 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633968977","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633968977?lang=en_us&edition=fundamental","pubTime":"2026-05-05 03:18","pubTimestamp":1777922288,"startTime":"0","endTime":"0","summary":"Pampa Energia SA  expected to post earnings of $1.15 a share - Earnings Preview Pampa Energia SA PAM.N, PAM is expected to  show a rise in quarterly revenue when it reports  results on May 6 for the p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H21B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4081","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632580930","title":"Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2632580930","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632580930?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892400,"startTime":"0","endTime":"0","summary":"Total 1Q 2026 net product revenue of $191.2 million, representing 57% year-over-year growth AUVELITY 1Q 2026 net product sales of $153.2 million, representing 59% year-over-year growth SUNOSI 1Q 2026 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286568/33090/en/Axsome-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","PAM","BK4585","BK4505","ADHD","BK4081","BK4007","AXSM","BK4135","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108668461","title":"Earning Preview: Pampa Energia SA this quarter’s revenue is expected to increase by 22.59%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1108668461","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108668461?lang=en_us&edition=fundamental","pubTime":"2026-04-30 01:06","pubTimestamp":1777482419,"startTime":"0","endTime":"0","summary":"Abstract Pampa Energia SA is scheduled to release results on May 6, 2026, Post Market; this preview synthesizes the latest quarter’s performance, consensus for the upcoming quarter, and recent...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Pampa Energia SA this quarter’s revenue is expected to increase by 22.59%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631595029","title":"Addex Therapeutics announces GABAB PAM candidate data","url":"https://stock-news.laohu8.com/highlight/detail?id=2631595029","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631595029?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:35","pubTimestamp":1777455353,"startTime":"0","endTime":"0","summary":"Addex Therapeutics (ADXN) announced preclinical data demonstrating antitussive activity of its GABAB positive allosteric modulator candidate in a b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/addex-therapeutics-announces-gabab-pam-candidate-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/addex-therapeutics-announces-gabab-pam-candidate-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007","ADXN","PAM","BK4081","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631550195","title":"Press Release: Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2631550195","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631550195?lang=en_us&edition=fundamental","pubTime":"2026-04-29 13:00","pubTimestamp":1777438800,"startTime":"0","endTime":"0","summary":"Geneva, Switzerland, April 29, 2026 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today encouraging preclinical data demonstrating antitussive activity of its GABAB positive allosteric modulator  candidate in a bleomycin -induced idiopathic pulmonary fibrosis  exacerbated chronic cough model.\"Chronic cough remains a significant unmet medical need, particularly in patients suffering from idiopathic pulmonary fibrosis , where persistent coughing substantially impacts quality of life and worsens disease burden,\" said Tim Dyer, CEO of Addex. \"In studies to date, including non-human primates announced last week, robust antitussive efficacy of the compound is combined with a stable respiratory and systemic safety profile, further supporting the therapeutic promise of our GABAB PAM as a novel and well-tolerated approach for chronic cough management.\". Addex","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4139","ADXN","BK4007","BK4563","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629289322","title":"Major Insider Move Shakes Up the Outlook for Pampa Energia SA","url":"https://stock-news.laohu8.com/highlight/detail?id=2629289322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629289322?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:02","pubTimestamp":1776996159,"startTime":"0","endTime":"0","summary":"New insider activity at Pampa Energia SA ( ($PAM) ) has taken place on April 23, 2026. Director Marcos Marcelo Mindlin has executed a major divestm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-the-outlook-for-pampa-energia-sa-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-shakes-up-the-outlook-for-pampa-energia-sa-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PAM","BK4081","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629858677","title":"Creightons Rebrands as Potter & Moore with New PAM Ticker","url":"https://stock-news.laohu8.com/highlight/detail?id=2629858677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629858677?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:07","pubTimestamp":1776953250,"startTime":"0","endTime":"0","summary":"An announcement from Creightons ( ($GB:CRL) ) is now available. Potter & Moore Plc has confirmed its legal name change from Creightons Plc after re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/creightons-rebrands-as-potter-moore-with-new-pam-ticker?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/creightons-rebrands-as-potter-moore-with-new-pam-ticker?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4081","BK4563","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629009484","title":"Press Release: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629009484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629009484?lang=en_us&edition=fundamental","pubTime":"2026-04-23 13:00","pubTimestamp":1776920400,"startTime":"0","endTime":"0","summary":"Geneva, Switzerland, April 23, 2026 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that its spin-out company, Neurosterix, is on track to complete its Phase 1 clinical study evaluating NTX-253 in Q2 2026. NTX-253 is an investigational potent, selective, orally available positive allosteric modulator  of the muscarinic M4 receptor being developed for the treatment of schizophrenia. The study is designed to generate a robust early-stage clinical data package assessing safety, tolerability, and pharmacokinetics  across both healthy adult participants and those with stable schizophrenia.The clinical study includes a multi-part, ascending-dose design intended to efficiently characterize NTX-253's clinical profile and support subsequent patient-focused development. The study includes both single ascending dose  and multiple ascending dose  components,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","ADXN","BK4139","BK4007","BK4563","BK4181","PK","NTX","BK4081","CSF","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629557098","title":"Major Insider Move at Pampa Energia SA Shakes Up Investor Watchlists","url":"https://stock-news.laohu8.com/highlight/detail?id=2629557098","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629557098?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:03","pubTimestamp":1776823410,"startTime":"0","endTime":"0","summary":"New insider activity at Pampa Energia SA ( ($PAM) ) has taken place on April 21, 2026. Pampa Energia SA has seen notable insider activity as Direct...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-pampa-energia-sa-shakes-up-investor-watchlists-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-pampa-energia-sa-shakes-up-investor-watchlists-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4081","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629704657","title":"Press Release: Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2629704657","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629704657?lang=en_us&edition=fundamental","pubTime":"2026-04-21 13:00","pubTimestamp":1776747600,"startTime":"0","endTime":"0","summary":"Geneva, Switzerland, April 21, 2026 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor  positive allosteric modulator  in a non-human primate  chronic cough model.The main inhibitory neurotransmitter GABA activates ionotropic  and metabotropic  types of receptors. GABAB receptors are widely expressed throughout the central and peripheral cough neural circuit as well as in the lungs and airways. Activating GABAB receptors to treat chronic cough has been clinically validated with baclofen, a selective GABAB agonist, that binds the receptor within the GABA binding, orthosteric site. Baclofen is used off-label to treat chronic cough patients, but its wider use is limited due to serious side effects including sedation, short half-life and gradual loss of efficacy during","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","PAM","BK4563","ADXN","NHP","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628278613","title":"Optima Health lifts profit outlook and strengthens position with PAM acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2628278613","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628278613?lang=en_us&edition=fundamental","pubTime":"2026-04-17 14:24","pubTimestamp":1776407060,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Optima Health PLC ( ($GB:OPT) ). Optima Health plc, a UK-based leader in technology-enabled occupational health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-lifts-profit-outlook-and-strengthens-position-with-pam-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-lifts-profit-outlook-and-strengthens-position-with-pam-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","PAM","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623303610","title":"Optima Health Launches £35m Underwritten Open Offer to Fund PAM Deal and Boost Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2623303610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623303610?lang=en_us&edition=fundamental","pubTime":"2026-03-31 14:11","pubTimestamp":1774937488,"startTime":"0","endTime":"0","summary":"Optima Health PLC ( ($GB:OPT) ) has issued an update. Optima Health plc has launched an underwritten open offer to raise approximately £35m through...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-launches-35m-underwritten-open-offer-to-fund-pam-deal-and-boost-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-launches-35m-underwritten-open-offer-to-fund-pam-deal-and-boost-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4081","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623731901","title":"Press Release: Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623731901","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623731901?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:53","pubTimestamp":1774867980,"startTime":"0","endTime":"0","summary":"New data for NMRA-511 supports unsurpassed clinical effect in a pre-specified population comparable to Rexulti and Auvelity pivotal studies. KOASTAL-2 and -3 fully enrolled in the first quarter of 2026; on track for topline readout in the second quarter of 2026. NMRA-898 selected as lead program in M4 franchise based on promising clinical results from ongoing Phase 1 study. \"We saw significant progress in 2025, laying the foundation for a catalyst-rich year ahead as we advance our pipeline of next-generation therapies for people living with brain diseases,\" said Paul L. Berns, co-founder, chairman and chief executive officer of Neumora. \"In the first quarter of 2026, we confirmed next steps for navacaprant and our M4 franchise, as well as generated compelling results supporting the potential unsurpassed profile of NMRA-511 in Alzheimer's disease agitation, which we built upon today with the announcement of additional data from a pre-specified analysis.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4132","PAM","AD","NMRA","BK4563","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622094387","title":"Optima Health clears Irish FDI hurdle for £100m PAM acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2622094387","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622094387?lang=en_us&edition=fundamental","pubTime":"2026-03-25 00:42","pubTimestamp":1774370547,"startTime":"0","endTime":"0","summary":"Optima Health PLC ( ($GB:OPT) ) has shared an update. Optima Health has secured Irish foreign direct investment clearance for its approximately £10...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-clears-irish-fdi-hurdle-for-100m-pam-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-clears-irish-fdi-hurdle-for-100m-pam-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4081","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621720411","title":"Optima Health Plans CFO Transition Ahead of PAM Healthcare Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2621720411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621720411?lang=en_us&edition=fundamental","pubTime":"2026-03-23 15:15","pubTimestamp":1774250152,"startTime":"0","endTime":"0","summary":"Optima Health PLC ( ($GB:OPT) ) just unveiled an update. Optima Health plc, the UK’s leading provider of technology-enabled corporate health and we...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-plans-cfo-transition-ahead-of-pam-healthcare-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-plans-cfo-transition-ahead-of-pam-healthcare-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4563","HCSG","BK4137","LABU","LU0029874061.USD","BK4081","PAM","LU0128526141.USD","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618900205","title":"Pampa Energia Sa : HSBC Raises to Buy From Hold; Raises Target Price to $97 From $88","url":"https://stock-news.laohu8.com/highlight/detail?id=2618900205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618900205?lang=en_us&edition=fundamental","pubTime":"2026-03-12 14:22","pubTimestamp":1773296551,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4081","BK4563","PAM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pampa.com","stockEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.0401},{"period":"6month","weight":-0.0524},{"period":"1year","weight":0.014},{"period":"ytd","weight":-0.069}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.0668},{"period":"6month","weight":0.0984},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pampa Energía S.A. operates as an integrated power company in Argentina. The company operates through Electricity Generation, Oil and Gas, Petrochemicals, and Holding and Other Business segments. It generates electricity through thermal plants, hydroelectric plants, and wind farms with a 5,332 megawatt (MW) installed capacity. The company also explores for and produces oil and gas in the provinces of Neuquén and Río Negro. In addition, it produces petrochemicals, such as styrene, synthetic rubber, and polystyrene. Further, the company operates and maintains a 22,391 km high-voltage electricity transmission network in Argentina. Additionally, it holds a concession for the transportation of natural gas with 9,248 km of gas pipelines in the center, west, and south of Argentina; and processes and sells natural gas liquids in Bahía Blanca in the Province of Buenos Aires, as well as offers related advisory services. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energía S.A. in September 2008. Pampa Energía S.A. was incorporated in 1945 and is based in Buenos Aires, Argentina.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.026743},{"month":2,"riseRate":0.235294,"avgChangeRate":-0.035603},{"month":3,"riseRate":0.588235,"avgChangeRate":0.043228},{"month":4,"riseRate":0.294118,"avgChangeRate":-0.044556},{"month":5,"riseRate":0.588235,"avgChangeRate":0.024293},{"month":6,"riseRate":0.375,"avgChangeRate":0.002742},{"month":7,"riseRate":0.625,"avgChangeRate":0.033422},{"month":8,"riseRate":0.5,"avgChangeRate":-0.035441},{"month":9,"riseRate":0.5,"avgChangeRate":0.048997},{"month":10,"riseRate":0.8125,"avgChangeRate":0.115042},{"month":11,"riseRate":0.588235,"avgChangeRate":0.056056},{"month":12,"riseRate":0.470588,"avgChangeRate":0.016592}],"exchange":"NYSE","name":"Pampa Energia SA","nameEN":"Pampa Energia SA","securityTypeName":"DR","adrRate":"1:25"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pampa Energia SA(PAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pampa Energia SA(PAM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pampa Energia SA,PAM,Pampa Energia SA股票,Pampa Energia SA股票老虎,Pampa Energia SA股票老虎国际,Pampa Energia SA行情,Pampa Energia SA股票行情,Pampa Energia SA股价,Pampa Energia SA股市,Pampa Energia SA股票价格,Pampa Energia SA股票交易,Pampa Energia SA股票购买,Pampa Energia SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pampa Energia SA(PAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pampa Energia SA(PAM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction